Five things to know:
1. The project’s first initiative is an antibody research study that will be offered to individuals who have had a nasal swab test through Verily’s Baseline COVID-19 testing program.
2. With the antibody study, Verily will use serology testing to analyze national infection rates and determine whether antibodies grant protection against the novel coronavirus.
3. Verily is also offering research initiatives focused on improving the outcomes of those affected by COVID-19, such as surveys on mental health and lifestyle.
4. The COVID-19 Research Project is open to anyone who wants to participate, whether they have personally experienced COVID-19 or not. Project Baseline offers the research activities through an online member portal.
5. Since launching COVID-19 testing in California in March, Verily has expanded the program nationwide at 25 Rite Aid locations.
More articles on health IT:
What’s on the AI wish list for 3 healthcare execs
Lee Health to employ digital technology to limit COVID-19 exposure in potential surge
Execs share key trends in healthcare marketing amid pandemic: 3 insights
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.